DNM1L and Parkinson disease: Inhibition on Drp1 with Mdivi-1 specifically has been shown to reduce functional deficit in a retrograde toxin model of motor neuron degeneration in mouse [89] and provide neuroprotection in a rat model of Parkinson’s disease [90].